TFAP2C
TFAP2C (transcription factor AP-2 gamma, also known as AP2-GAMMA, ERF1, TFAP2G and hAP-2g) is a sequence-specific DNA-binding transcription factor of the AP-2 family. It regulates developmental genes and plays a key role in early embryonic development. Browse Assay Genie's current range of TFAP2C research reagents below, or read on for the biology behind the target.
TFAP2C is a sequence-specific DNA-binding transcription factor that interacts with cellular enhancer elements to regulate transcription of selected genes. Like other AP-2 factors, it binds the consensus sequence 5'-GCCNNNGGC-3' and activates genes involved in a large spectrum of biological functions. It can act as a homodimer or as a heterodimer with other family members, and it binds both closed and open chromatin together with other transcription factors.
The protein has a particularly well-described role in early embryogenesis, where it regulates differentiation of both the inner cell mass (ICM) and the trophectoderm. At the 8-cell stage, during morula development, it controls expression of cell-polarity genes. Once trophoblast commitment occurs, TFAP2C binds late trophectoderm genes in blastocysts together with CDX2, and later binds extra-embryonic ectoderm genes together with SOX2. The NCBI Gene summary adds that it is induced during retinoic acid-mediated differentiation and contributes to development of the eyes, face, body wall, limbs and neural tube.
The human TFAP2C gene encodes a nuclear protein of the AP-2 transcription factor family, which also includes TFAP2A and TFAP2B. The gene has also been known as TFAP2G, and the protein as activating enhancer-binding protein 2 gamma. In breast cancer, TFAP2C is involved in the MTA1-mediated epigenetic regulation of ESR1 expression. The mouse ortholog is Tfap2c.
TFAP2C regulates inner cell mass and trophectoderm differentiation and controls cell-polarity genes at the 8-cell morula stage.
It binds late trophectoderm genes with CDX2 and extra-embryonic ectoderm genes with SOX2, making it a focus for lineage specification studies.
TFAP2C contributes to development of the eyes, face, body wall, limbs and neural tube, and is induced during retinoic acid-mediated differentiation.
TFAP2C takes part in MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer.
TFAP2C is a sequence-specific DNA-binding transcription factor that binds the consensus 5'-GCCNNNGGC-3' at enhancer elements and activates selected genes. It regulates inner cell mass and trophectoderm differentiation in early embryos and acts as a homodimer or as a heterodimer with other AP-2 family members.
The HGNC name is transcription factor AP-2 gamma, previously activating enhancer-binding protein 2 gamma. Aliases include AP2-GAMMA, ERF1, TFAP2G and hAP-2g. UniProt lists the protein as Transcription factor AP-2 gamma, and it belongs to the AP-2 family alongside TFAP2A and TFAP2B.
UniProt links TFAP2C to the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer. A mouse ortholog, Tfap2c, is annotated, and its developmental roles are studied in that species. Please check the datasheet of any product for its validated reactivity.
Other AP-2 family transcription factors with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92754; product specifications from Assay Genie datasheets.